当前位置: X-MOL 学术Lancet Diabetes Endocrinol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
GLP-1 receptor agonists: which added value when increasing the dose?
The Lancet Diabetes & Endocrinology ( IF 44.0 ) Pub Date : 2021-07-21 , DOI: 10.1016/s2213-8587(21)00205-9
André J Scheen 1
Affiliation  



中文翻译:

GLP-1 受体激动剂:增加剂量时有哪些附加值?

更新日期:2021-07-19
down
wechat
bug